Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Multicenter, Prospective, Randomized, Double-blind Study Comparing the Efficacy and Safety of Therapy for Scabies With Two Differently Concentrated Permethrin Creams.

NCT06380452 is registered in ClinicalTrials.gov with Infectopharm Arzneimittel GmbH as lead sponsor.

NCT NCT06380452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06380452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Multicenter, Prospective, Randomized, Double-blind Study Comparing the Efficacy and Safety of Therapy for Scabies With Two Differently Concentrated Permethrin Creams.
Lead sponsor
Infectopharm Arzneimittel GmbH
Phase
Phase 3
Overall status
Not yet recruiting
Start date
May 31, 2024
Completion date
December 31, 2028
Enrollment
220 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

scabies